AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

POLAR CAPITAL GLOBAL HEALTH.TST PLC

Related Party Transaction Oct 14, 2020

5198_rns_2020-10-14_f3b00cd5-25ca-48c1-b0f4-2a10f9177e60.html

Related Party Transaction

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 0955C

Polar Capital Global Health Tst PLC

14 October 2020

POLAR CAPITAL GLOBAL HEALTHCARE TRUST PLC (the 'Company')

LEI: 549300YV7J2TWLE7PV84

14 October 2020

Management Fee Arrangements

The Board of Directors announces that following discussion with Polar Capital they have agreed a reduction in the management fee charged for managing the portfolio.

The base management fee prior to the revision was 0.85% per annum based on the lower of the market capitalisation and adjusted net asset value.

The revised management fee, which is in place with effect from 1 October 2020, is 0.75% per annum based on the lower of the market capitalisation and adjusted net asset value.

All other terms within the Investment Management Agreement remain unchanged.

The Chairman commented: 'The absolute performance of the Trust has been positive in recent months, but its relative performance has been behind its benchmark. The Board appreciates that Polar Capital has had regard to this and has proposed this material reduction in the management fee rate. The Board remains confident in the Investment Manager's strategic approach to investing in the healthcare market and will report in more detail in the forthcoming Annual Report for the year ended 30 September 2020'.

For further information please contact: Lisa Arnold - Chairman

Polar Capital Global Healthcare Trust Plc

Iain Evans

Polar Capital Head of Global Distribution

Tracey Lago

Company Secretary
Tele: 020 7227 2700

Tele. 020 7227 2740

Tele. 020 7227 2742

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCDZMMGZDFGGZM

Talk to a Data Expert

Have a question? We'll get back to you promptly.